The Harry T. Mangurian Jr. Foundation has granted the Mayo Clinic in…
Ana de Barros, PhD
Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana de Barros, PhD
According to a recent study from a team of researchers at Tel Aviv University, a mutation in a specific neuroprotective…
A recent study titled ”Individuals with Alzheimer’s disease exhibit a high prevalence of undiagnosed impaired glucose…
Pharnext, a biopharmaceutical company that develops therapeutics called pleodrugs that simultaneously target multiple key disease pathways for serious orphan…
A team of researchers from Japan found that Alzheimer’s symptoms can be reduced when sugars are averted from binding…
Patients receiving treatment to correct or control atrial fibrillation, and end up being “overtreated” for a long period of time…
A team of researchers from Australia aimed to determine the occurrence of eating abnormalities in subtypes of frontotemporal…
Neurodegenerative diseases such as Alzheimer’s can provoke a neural dysfunction that affects the patient’s behavior, leading to criminality. This is…
The in-home care provider for seniors in the U.S. and Canada, Home Care Assistance of Toronto,…
A new treatment strategy for inherited dementia and Alzheimer’s disease was identified using stem cells derived…